Alignment Healthcare, Inc. (ALHC) SEC Filings & Earnings Calls
EquiReason read 13 Alignment Healthcare, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-10-08 — CMS released 2027 Star Ratings; ALHC's largest plan (75% of membership) dropped from 4.0 to 3.5 stars due to higher industry cut points and triple-weighted measure declines. Compan.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 1.7B
- P/E TTM
- 42.4
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
8 Oct 20268-K · 7.01CMS released 2027 Star Ratings; ALHC's largest plan (75% of membership) dropped from 4.0 to 3.5 stars due to higher industry cut points and triple-weighted measure declines. Company plans litigation and administrative appeals.open
Figures in the filing · each found in the filing text
| Health Plan Membership · California HMO (H3815) · 2026-10-08 | 75.0% | |
| Star Rating · California HMO (H3815) · 2027 | $3.50 | -13% y/y |
Risks flagged
Star rating decline for 75% of membership reduces quality bonus payments in FY2028, creating revenue headwind.
“The change in Star Ratings performance for rating year 2027 will impact the Company’s quality bonus payments for fiscal year 2028.” · word for word
CMS retroactive elimination of Health Equity Index bonus undermines prior investments and creates regulatory unpredictability.
“CMS’s decision to retroactively eliminate bonus calculations related to the Excellent Health Outcomes for All Index... reduced the impact of investments that the Company made to align with CMS’s objectives.” · word for word
Litigation and administrative appeals may not succeed; uncertainty around future star ratings and financial impact.
“The Company intends to pursue available administrative appeals... and expects to commence litigation challenging certain Star Ratings measures and methodologies.” · word for word
30 Jul 20268-K · 2.02Total revenue $1.34B (+32% y/y); Health plan membership 294,100 (+32% y/y); Adjusted gross profit $183M (+35% y/y); Guidance: FY2026 revenue guidance raised to $5,195-$5,225M; adjusted EBITDA to $145-$163M; membership to 298,000-301,000earningsopen
Figures in the filing · each found in the filing text
| Total revenue · Q2-2026 | $1.34B | +32% y/y |
| Health plan membership · Q2-2026 | 294,100 | +32% y/y |
| Adjusted gross profit · Q2-2026 | $183M | +35% y/y |
| Adjusted EBITDA · Q2-2026 | $68M | +48% y/y |
| Net income · Q2-2026 | $37M | +134% y/y |
| Medical benefits ratio · Q2-2026 | 86.3% |
Guidance
FY2026 revenue guidance raised to $5,195-$5,225M; adjusted EBITDA to $145-$163M; membership to 298,000-301,000
Raised midpoint of all full-year guidance metrics: membership, revenue, adjusted gross profit, adjusted EBITDA
30 Jul 202610-QNet income $37M (+134% y/y); Diluted income per share $0.17 (+143% y/y); Net income $48M (+662% y/y)open
Figures in the filing · each found in the filing text
| Net income · Q2-2026 | $37M | +134% y/y |
| Diluted income per share · Q2-2026 | $0.17 | +143% y/y |
| Net income · H1-2026 | $48M | +662% y/y |
| Diluted income per share · H1-2026 | $0.22 | +633% y/y |
Risks flagged
RADV audit exposure
“On June 25, 2025, the Company was notified that its California HMO plan had been selected for an audit of Medicare Advantage contract-specific risk adjustment data validation (“RADV”) with respect to payment year 2019.” · word for word
Whistleblower lawsuit
“On July 7, 2026, a former executive officer filed a lawsuit against the Company and certain officers in the U.S. District Court for the Central District of California alleging whistleblower retaliation, constructive discharge, breach of contract and compensation-related claims.” · word for word
Regulatory compliance cost
“Our recognized premium revenue for our Medicare Advantage Plans are each subject to a minimum annual medical loss ratio (“MLR”) of 85 %.” · word for word
30 Apr 202610-QNet income (loss) $11M (+222% y/y); Diluted income (loss) per share $0.05 (+200% y/y)open
Figures in the filing · each found in the filing text
| Net income (loss) · Q1-2026 | $11M | +222% y/y |
| Diluted income (loss) per share · Q1-2026 | $0.05 | +200% y/y |
Risks flagged
RADV audit exposure
“On June 25, 2025, the Company was notified that its California HMO plan had been selected for an audit of Medicare Advantage contract-specific risk adjustment data validation (“RADV”) with respect to payment year 2019.” · word for word
Regulatory compliance cost
“Our recognized premium revenue for our Medicare Advantage Plans are each subject to a minimum annual medical loss ratio (“MLR”) of 85 %.” · word for word
30 Apr 20268-K · 2.02Total revenue $1.24B (+33% y/y); Health Plan Membership 284,800 (+31% y/y); Adjusted Gross Profit $146M (+36% y/y); Guidance: FY2026 revenue $5,160-5,205M; Adj. gross profit $620-650M; Adj. EBITDA $138-163M; membership 294,000-299,000earningsopen
Figures in the filing · each found in the filing text
| Total revenue · Q1-2026 | $1.24B | +33% y/y |
| Health Plan Membership · Q1-2026 | 284,800 | +31% y/y |
| Adjusted Gross Profit · Q1-2026 | $146M | +36% y/y |
| Medical Benefits Ratio (MBR) based on adjusted gross profit · Q1-2026 | 88.2% | |
| Adjusted EBITDA · Q1-2026 | $38M | +88% y/y |
| Adjusted EBITDA margin · Q1-2026 | 3.1% | |
| Net income (loss) · Q1-2026 | $11M | |
| Income (loss) from operations · Q1-2026 | $16M |
Guidance
FY2026 revenue $5,160-5,205M; Adj. gross profit $620-650M; Adj. EBITDA $138-163M; membership 294,000-299,000
Raised midpoint of all guidance metrics; strong Q1 beat; membership growth accelerating; margin expansion; swing to profitability.
Risks flagged
Medicare Advantage environment changing; regulatory/policy risk could impact margins.
“even as the Medicare Advantage environment continues to change” · word for word
Equity-based compensation ($12.6M in SG&A, $1.4M in medical expenses) dilutes shareholders.
“selling, general, and administrative expenses of $121.1 million (which includes $12.6 million of equity-based compensation)” · word for word
24 Apr 2026DEF 14AAnnual proxy statement filed; no material event, but provides detailed insight into executive compensation structure and pay-for-performance alignment.open
Figures in the filing · each found in the filing text
| Health Plan Membership · FY2025 | 236,300 | +25% y/y |
| Net Income (Loss) · FY2025 | $-1M | |
| Adjusted EBITDA · FY2025 | $110M | |
| Medical Benefits Ratio (MBR) · FY2025 | 87.5% | |
| Adjusted Gross Profit · FY2025 | $495M |
Risks flagged
Medicare Advantage Regulatory Risk
“This progress was achieved in a dynamic MA environment marked by higher utilization, evolving risk adjustment standards and increased regulatory scrutiny.” · word for word
Competition for Talent
“In light of the Company’s retention objectives given competition for talent in the health care space.” · word for word
4 Mar 20268-K · 1.01Alignment Healthcare entered an underwriting agreement for a secondary offering of 13,167,733 shares by a selling stockholder; company receives no proceeds.open
Risks flagged
Insider selling may indicate lack of confidence; dilution of existing shareholders (though secondary).
“13,167,733 shares sold by selling stockholder.”
27 Feb 202610-KHealth Plan Membership 236,300; Revenue 5-Year CAGR 36; Health Plan Membership 5-Year CAGR 29open
Figures in the filing · each found in the filing text
| Health Plan Membership · FY2025 | 236,300 | |
| Revenue 5-Year CAGR · FY2025 | 36.0% | |
| Health Plan Membership 5-Year CAGR · FY2025 | 29.0% | |
| Clinical Employees · FY2025 | 450 | |
| Markets Served · FY2025 | 45 | |
| Medicare-Eligible Seniors in Service Area · FY2025 | 8,400,000 |
Risks flagged
Regulatory Dependency on CMS
“If any of our operations or those of our affiliated professional medical corporations are found to violate applicable laws or regulations, or if we otherwise fail to adhere to our contracts with CMS, we could suffer severe consequences...” · word for word
Star Rating Risk
“Medicare Advantage plans with higher Star Ratings receive additional economic incentives and payments.” · word for word
Medical Cost Ratio Risk
“We are responsible for delivering and coordinating all covered healthcare services for our members.” · word for word
Cybersecurity and Data Privacy
“We are subject to data privacy and protection and breach notification laws and regulations...” · word for word
Geographic Concentration
“the concentration of our health plans in a limited number of U.S. states” · word for word
26 Feb 20268-K · 2.02Health Plan Membership 236,300 (+25% y/y); Total Revenue $1.01B (+44% y/y); Adjusted Gross Profit $125M; Guidance: FY2026 revenue guidance $5.14-5.19B vs FY2025 $3.95B (+30-31%)earningsopen
Figures in the filing · each found in the filing text
| Health Plan Membership · Q4-2025 | 236,300 | +25% y/y |
| Total Revenue · Q4-2025 | $1.01B | +44% y/y |
| Adjusted Gross Profit · Q4-2025 | $125M | |
| Adjusted EBITDA · Q4-2025 | $11M | |
| Medical Benefits Ratio · Q4-2025 | 87.7% | |
| Total Revenue FY · FY2025 | $3.95B | +46% y/y |
| Adjusted Gross Profit FY · FY2025 | $495M | |
| Adjusted EBITDA FY · FY2025 | $110M | |
| Revenue Guidance FY2026 · FY2026 | $5.19B | |
| Adjusted EBITDA Guidance FY2026 · FY2026 | $163M |
Guidance
FY2026 revenue guidance $5.14-5.19B vs FY2025 $3.95B (+30-31%)
Strong guidance raise with revenue growth and margin expansion.
Risks flagged
Regulatory risk in Medicare Advantage; medical cost inflation.
“Medical benefits ratio sensitivity; regulatory environment for Medicare Advantage.”
12 Jan 20268-K · 7.01Health plan membership 275,300 (+31% y/y); Adjusted EBITDA (consensus) $145M; Guidance: Year-end 2026 membership guidance 290k-296k (24-27% growth); consensus EBITDA ~$145M within rangeopen
Figures in the filing · each found in the filing text
| Health plan membership · 2026-01-01 | 275,300 | +31% y/y |
| Adjusted EBITDA (consensus) · FY2026 | $145M |
Guidance
Year-end 2026 membership guidance 290k-296k (24-27% growth); consensus EBITDA ~$145M within range
Company raises 2026 membership guidance and signals EBITDA will meet consensus, reflecting strong demand and margin confidence.
Risks flagged
Medicare Advantage funding risk: potential federal reductions in MA funding could impact revenue and margins.
“Risks associated with being a government contractor, including potential federal reductions in MA funding” · word for word
Regulatory and competitive pressures in Medicare Advantage market could affect membership growth and profitability.
“Changes in laws and regulations applicable to our business model; ability to maintain high star ratings” · word for word
30 Oct 20258-K · 2.02Health plan membership 229,600 (+26% y/y); Revenue $994M (+44% y/y); Adjusted gross profit $128M; Guidance: FY2025 revenue raised to $3.931B-$3.946B, adjusted EBITDA to $90M-$98Mearningsopen
Figures in the filing · each found in the filing text
| Health plan membership · Q3-2025 | 229,600 | +26% y/y |
| Revenue · Q3-2025 | $994M | +44% y/y |
| Adjusted gross profit · Q3-2025 | $128M | |
| Adjusted EBITDA · Q3-2025 | $32M | |
| Medical benefits ratio · Q3-2025 | 87.2% | |
| Net income · Q3-2025 | $4M |
Guidance
FY2025 revenue raised to $3.931B-$3.946B, adjusted EBITDA to $90M-$98M
Raised full-year 2025 guidance across all key metrics: membership, revenue, adjusted gross profit, adjusted EBITDA.
Risks flagged
Guidance raise indicates strong execution but competitive pressures in Medicare Advantage remain.
“Raises full-year outlook across all key metrics” · word for word
30 Oct 202510-QAlignment Healthcare reported net income of $3.7M in Q3 2025, a significant improvement from a net loss of $26.4M in Q3 2024, driven by revenue growth and favorable claims development.earningsopen
Figures in the filing · each found in the filing text
| Net income (loss) attributable to Alignment Healthcare, Inc. · Q3-2025 | $4M | |
| Revenue (incurred current year) · Q3-2025 | $849M | +37% y/y |
| Medical expenses payable · Q3-2025 | $529M | |
| EPS diluted · Q3-2025 | $0.02 |
Risks flagged
RADV audit risk
“On June 25, 2025, the Company was notified that its California HMO plan had been selected for an audit of Medicare Advantage contract-specific risk adjustment data validation (“RADV”) with respect to payment year 2019.” · word for word
Regulatory compliance cost
“in May 2025, CMS announced a significant expansion to its RADV audit program, stating, among other things, that it intended to conduct RADV audits with extrapolation on all eligible MA plans on an annual basis” · word for word
Litigation risk
“On April 27, 2022, a former employee of the Company filed a purported class action lawsuit ... alleging that the Company failed to provide hourly employees with required meal and rest breaks” · word for word
Alignment Healthcare, Inc. — questions
- What did Alignment Healthcare, Inc. file recently?
- 13 SEC filings in the last 12 months. Latest: 8-K on 2026-10-08 — CMS released 2027 Star Ratings; ALHC's largest plan (75% of membership) dropped from 4.0 to 3.5 stars due to higher industry cut points and triple-weighted measure declines. Company plans litigation and administrative appeals.
Every figure on this page comes from Alignment Healthcare, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.